VCAM1 and diabetes mellitus: In a diabetes-accelerated atherosclerotic model, the H2S donor GYY4137 reduced plaque formation, NLRP3 inflammasome activation, and the expression of both intercellular cell adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) [150].